Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NGX-267, a muscarinic M1 agonist, is used potentially for the treatment of Xerostomia, Alzheimer's disease and cognitive.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | NGX-267, a muscarinic M1 agonist, is used potentially for the treatment of Xerostomia, Alzheimer's disease and cognitive. |
別名 | AF-267B, AF267B, AF 267B, NGX 267 |
分子量 | 214.33 |
分子式 | C10H18N2OS |
CAS No. | 503431-81-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NGX-267 503431-81-0 AF-267B NGX267 AF267B AF 267B NGX 267 Inhibitor inhibitor inhibit